Megan E. Riehl

Megan E. Riehl

Auto-generated profile, based on publicly available information

Megan E. Riehl

Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2016 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
TTTiffany Taft
Tiffany Taft
MRM. Riehl
M. Riehl
JSJ. B. Sodikoff
J. B. Sodikoff
PKP. J. Kahrilas
P. J. Kahrilas
LKL. Keefer
L. Keefer
JPJ. E. Pandolfino
J. E. Pandolfino

3 April 2014 in Diseases of the Esophagus
Verified
Journal Article
Closed access
PDF file
MRM. E. Riehl
M. E. Riehl
SKS. Kinsinger
S. Kinsinger
PKP. J. Kahrilas
P. J. Kahrilas
JPJ. E. Pandolfino
J. E. Pandolfino
LKL. Keefer
L. Keefer

30 March 2015 in Diseases of the Esophagus
Verified
Journal Article
Closed access
PDF file
MRM. E. Riehl
M. E. Riehl
JPJ. E. Pandolfino
J. E. Pandolfino
OPO. S. Palsson
O. S. Palsson
LKL. Keefer
L. Keefer

5 June 2015 in American Journal of Clinical Hypnosis
Verified
Journal Article
Closed access
MRMegan E. Riehl
Megan E. Riehl
LKLaurie Keefer
Laurie Keefer
Hypnotherapy is an evidence based intervention for the treatment of functional bowel disorders, particularly irritable bowel syndrome. While similar in pathophysiology, less is known about the utility of hypnotherapy in the upper gastrointestinal tract. Esophageal disorders, most of which are functional in nature, cause painful and uncomfortable symptoms that impact patient quality of life and are difficult to treat from a medical perspective. After a thorough medical workup and a failed trial of proton pump inhibitor therapy, options for treatment are significantly limited. While the pathophysiology is likely multifactorial, two critical factors are believed to drive esophageal symptoms—visceral hypersensitivity and symptom hypervigilance. The goal of esophageal directed hypnotherapy is to promote a deep state of relaxation with focused attention allowing the patient to learn to modulate physiological sensations and symptoms that are not easily addressed with conventional medical intervention. Currently, the use of hypnosis is suitable for dysphagia, globus, functional chest pain/non-cardiac chest pain, dyspepsia, and functional heartburn. In this article the authors will provide a rationale for the use of hypnosis in these disorders, presenting the science whenever available, describing their approach with these patients, and sharing a case study representing a successful outcome.

16 May 2014 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
TTTiffany Taft
Tiffany Taft
MRM. E. Riehl
M. E. Riehl
KDK. L. Dowjotas
K. L. Dowjotas
LKL. Keefer
L. Keefer

9 June 2018 in Current Gastroenterology Reports
Verified
Journal Article
Closed access
PDF file
MRMegan E. Riehl
Megan E. Riehl
JCJoan W. Chen
Joan W. Chen